Retinoblastoma: Animal models

Ophthalmology Clinics of North America

Volumn 18, Issue 1, 2005, Pages 25-39

  Conway, R Max ^a,b   Wheeler, Sharon M ^a   Murray, Timothy G ^c   Jockovich, Maria Elena ^c   O'Brien, Joan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; ALPHA CRYSTALLIN; ANECORTAVE; CARBOPLATIN; COMBRETASTATIN A4; CRYSTALLIN; DOXERCALCIFEROL; ETOPOSIDE; OPSIN; RETINOBLASTOMA PROTEIN; VINCRISTINE; VIRUS T ANTIGEN; VITAMIN D DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL CYCLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CRYOTHERAPY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GASTROENTERITIS; GENETIC ENGINEERING; HUMAN; IONTOPHORESIS; KNOCKOUT MOUSE; MEDICAL RESEARCH; NAUSEA AND VOMITING; NONHUMAN; OPTIC NERVE ATROPHY; OTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RETINOBLASTOMA; TOXICITY; TRANSGENIC MOUSE; TUMOR GROWTH; VIRUS ONCOGENE; WART VIRUS; XENOGRAFT;

EID: 14844282088     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2004.08.006     Document Type: Review

References (106)

1. T.P. Dryja, W. Cavenee, R. White, J.M. Rapaport, R. Petersen, and D.M. Albert Homozygosity of chromosome 13 in retinoblastoma N Engl J Med 310 9 1984 550 553
2. S.H. Friend, R. Bernards, S. Rogelj, R.A. Weinberg, J.M. Rapaport, and D.M. Albert A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323 6089 1986 643 646
3. W.G. Kaelin Jr Functions of the retinoblastoma protein Bioessays 21 11 1999 950 958
4. P. Whyte, K.J. Buchkovich, J.M. Horowitz, S.H. Friend, M. Raybuck, and R.A. Weinberg Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product Nature 334 6178 1988 124 129
5. J.A. DeCaprio, J.W. Ludlow, J. Figge, J.Y. Shew, C.M. Huang, and W.H. Lee SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene Cell 54 2 1988 275 283
6. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 4893 1989 934 937
7. E. Moran, and M.B. Matthews Multiple functional domains in the adenovirus E1A gene Cell 48 2 1987 177 178
8. P. Whyte, N.M. Williamson, and E. Harlow Cellular targets for transformation by the adenovirus E1A proteins Cell 56 1 1989 67 75
9. D.V. Heck, C.L. Yee, P.M. Howley, and K. Munger Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc Natl Acad Sci USA 89 10 1992 4442 4446
10. K. Buchkovich, L.A. Duffy, and E. Harlow The retinoblastoma protein is phosphorylated during specific phases of the cell cycle Cell 58 6 1989 1097 1105
11. P.L. Chen, P. Scully, J.Y. Shew, J.Y. Wang, and W.H. Lee Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation Cell 58 6 1989 1193 1198
12. J.W. Ludlow, J.A. DeCaprio, C.M. Huang, W.H. Lee, E. Paucha, and D.M. Livingston SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family Cell 56 1 1989 57 65
13. M.M. Lipinski, and T. Jacks The retinoblastoma gene family in differentiation and development Oncogene 18 55 1999 7873 7882
14. E.S. Hickman, M.C. Moroni, and K. Helin The role of p53 and pRb in apoptosis and cancer Curr Opin Genet Dev 12 1 2002 60 66
15. S. Kobayashi, and N. Mukai Retinoblastoma-like tumors induced in rats by human adenovirus Invest Ophthalmol Vis Sci 12 11 1973 853 856
16. N. Mukai, S.S. Kalter, L.B. Cummins, V.A. Matthews, T. Nishida, and T. Nakajima Retinal tumor induced in the baboon by human adenovirus 12 Science 210 4473 1980 1023 1025
17. S.J. Sabet, S.R. Darjatmoko, M.J. Lindstrom, and D.M. Albert Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors Arch Ophthalmol 117 3 1999 365 370
18. S.A. Madreperla, J.A. Whittum-Hudson, R.A. Prendergast, P.L. Chen, and W.H. Lee Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells Cancer Res 51 23 Pt 1 1991 6381 6384
19. S.G. Rowe, W.H. Lee, and S. Madreperla Subretinal and vitreal growth of human retinoblastoma cells in the mouse eye [abstract] Invest Ophthalmol Vis Sci 33 4 1992 875
20. M. del Cerro, G.M. Seigel, E. Lazar, D. Grover, C. del Cerro, and D.H. Brooks Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas Invest Ophthalmol Vis Sci 34 12 1993 3336 3346
21. J.W. Streilein Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation J Leukoc Biol 74 2 2003 179 185
22. P. Chevez-Barrios, M.Y. Hurwitz, K. Louie, K.T. Marcus, V.N. Holcombe, and P. Schafer Metastatic and nonmetastatic models of retinoblastoma Am J Pathol 157 4 2000 1405 1412
23. R.L. Brinster, and R.D. Palmiter Introduction of genes into the germ line of animals Harvey Lect 80 1984-85 1 38
24. G. Barbanti-Brodano, S. Sabbioni, F. Martini, M. Negrini, A. Corallini, and M. Tognon Simian virus 40 infection in humans and association with human diseases: results and hypotheses Virology 318 1 2004 1 9
25. H. Stubdal, J. Zalvide, K.S. Campbell, C. Schweitzer, T.M. Roberts, and J.A. DeCaprio Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen Mol Cell Biol 17 9 1997 4979 4990
26. M. Classon, and E. Harlow The retinoblastoma tumour suppressor in development and cancer Nat Rev Cancer 2 12 2002 910 917
27. J.J. Windle, D.M. Albert, J.M. O'Brien, D.M. Marcus, C.M. Disteche, and R. Bernards Retinoblastoma in transgenic mice Nature 343 6259 1990 665 669
28. J.M. O'Brien, D.M. Marcus, R. Bernards, J.L. Carpenter, J.J. Windle, and P. Mellon A transgenic mouse model for trilateral retinoblastoma Arch Ophthalmol 108 8 1990 1145 1151
29. J.M. O'Brien, D.M. Marcus, A.S. Niffenegger, R. Bernards, J.L. Carpenter, and J.J. Windle Trilateral retinoblastoma in transgenic mice Trans Am Ophthalmol Soc 87 1989 301 326
30. A.P. Kyritsis, M. Tsokos, T.J. Triche, and G.J. Chader Retinoblastoma: a primitive tumor with multipotential characteristics Invest Ophthalmol Vis Sci 27 12 1986 1760 1764
31. D.M. Marcus, J.M. O'Brien, and J. Sahel The histogenesis of transgenic murine retinoblastoma [abstract] Invest Ophthalmol Vis Sci 33 Suppl 1992 875
32. T. Kivela, I. Virtanen, D.M. Marcus, J.M. O'Brien, J.L. Carpenter, and E. Brauner Neuronal and glial properties of a murine transgenic retinoblastoma model Am J Pathol 138 5 1991 1135 1148
33. E. Bogenmann, M.A. Lochrie, and M.I. Simon Cone cell-specific genes expressed in retinoblastoma Science 240 4848 1988 76 78
34. T. Vrabec, V. Arbizo, G. Adamus, J.H. McDowell, P.A. Hargrave, and L.A. Donoso Rod cell-specific antigens in retinoblastoma Arch Ophthalmol 107 7 1989 1061 1063
35. R.L. Hurwitz, E. Bogenmann, R.L. Font, V. Holcombe, and D. Clark Expression of the functional cone phototransduction cascade in retinoblastoma J Clin Invest 85 6 1990 1872 1878
36. D.M. Marcus, S.E. Brooks, G. Leff, R. McCormick, T. Thompson, and S. Anfinson Trilateral retinoblastoma: insights into histogenesis and management Surv Ophthalmol 43 1 1998 59 70
37. D.M. Marcus, J.L. Carpenter, J.M. O'Brien, T. Kivela, E. Brauner, and A. Tarkkanen Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma Invest Ophthalmol Vis Sci 32 2 1991 293 301
38. D.M. Marcus, J.G. Lasudry, J.L. Carpenter, J. Windle, K.A. Howes, and M.R. al-Ubaidi Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen Invest Ophthalmol Vis Sci 37 2 1996 392 396
39. M.R. al-Ubaidi, R.L. Font, A.B. Quiambao, M.J. Keener, G.I. Liou, and P.A. Overbeek Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter J Cell Biol 119 6 1992 1681 1687
40. K.A. Howes, J.G. Lasudry, D.M. Albert, and J.J. Windle Photoreceptor cell tumors in transgenic mice Invest Ophthalmol Vis Sci 35 2 1994 342 351
41. K. Porrello, S.P. Bhat, and D. Bok Detection of interphotoreceptor retinoid binding protein (IRBP) mRNA in human and cone-dominant squirrel retinas by in situ hybridization J Histochem Cytochem 39 2 1991 171 176
42. M.R. al-Ubaidi, J.G. Hollyfield, P.A. Overbeek, and W. Baehr Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice Proc Natl Acad Sci USA 89 4 1992 1194 1198
43. K.A. Mahon, A.B. Chepelinsky, J.S. Khillan, P.A. Overbeek, J. Piatigorsky, and H. Westphal Oncogenesis of the lens in transgenic mice Science 235 4796 1987 1622 1628
44. K. Munger, J.R. Basile, S. Duensing, A. Eichten, S.L. Gonzalez, and M. Grace Biological activities and molecular targets of the human papillomavirus E7 oncoprotein Oncogene 20 54 2001 7888 7898
45. J.O. Funk, S. Waga, J.B. Harry, E. Espling, B. Stillman, and D.A. Galloway Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein Genes Dev 11 16 1997 2090 2100
46. S. Duensing, and K. Munger Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins Int J Cancer 109 2 2004 157 162
47. M. Scheffner, J.M. Huibregtse, R.D. Vierstra, and P.M. Howley The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 3 1993 495 505
48. A.E. Griep, R. Herber, S. Jeon, J.K. Lohse, R.R. Dubielzig, and P.F. Lambert Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation J Virol 67 3 1993 1373 1384
49. A.E. Griep, J. Krawcek, D. Lee, A. Liem, D.M. Albert, and R. Carabeo Multiple genetic loci modify risk for retinoblastoma in transgenic mice Invest Ophthalmol Vis Sci 39 13 1998 2723 2732
50. K.A. Howes, N. Ransom, D.S. Papermaster, J.G. Lasudry, D.M. Albert, and J.J. Windle Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53 Genes Dev 8 11 1994 1300 1310
51. D.S. Papermaster, and J. Windle Death at an early age: apoptosis in inherited retinal degenerations Invest Ophthalmol Vis Sci 36 6 1995 977 983
52. M.D. Mills, J.J. Windle, and D.M. Albert Retinoblastoma in transgenic mice: models of hereditary retinoblastoma Surv Ophthalmol 43 6 1999 508 518
53. J.A. Majzoub, and L.J. Muglia Knockout mice N Engl J Med 334 14 1996 904 907
54. A.R. Clarke, E.R. Maandag, M. van Roon, N.M. van der Lugt, M. van der Valk, and M.L. Hooper Requirement for a functional Rb-1 gene in murine development Nature 359 6393 1992 328 330
55. N. Hu, A. Gutsmann, D.C. Herbert, A. Bradley, W.H. Lee, and E.Y. Lee Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance Oncogene 9 4 1994 1021 1027
56. T. Jacks, A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg Effects of an Rb mutation in the mouse Nature 359 6393 1992 295 300
57. E.Y. Lee, C.Y. Chang, N. Hu, Y.C. Wang, C.C. Lai, and K. Herrup Mice deficient for RB are nonviable and show defects in neurogenesis and haematopoiesis Nature 359 6393 1992 288 300
58. J. Squire, A.D. Goddard, M. Canton, A. Becker, R.A. Phillips, and B.L. Gallie Tumour induction by the retinoblastoma mutation is independent of N-myc expression Nature 322 6079 1986 555 557
59. B.O. Williams, E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, and R.A. Weinberg Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences EMBO J 13 18 1994 4251 4259
60. M.H. Lee, B.O. Williams, G. Mulligan, S. Mukai, R.T. Bronson, and N. Dyson Targeted disruption of p107: functional overlap between p107 and Rb Genes Dev 10 13 1996 1621 1632
61. E.C. Maandag, M. van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, and M. van Roon Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice EMBO J 13 18 1994 4260 4268
62. D. Cobrinik, M.H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, and N. Dyson Shared role of the pRB-related p130 and p107 proteins in limb development Genes Dev 10 13 1996 1633 1644
63. E. Robanus-Maandag, M. Dekker, M. van der Valk, M.L. Carrozza, J.C. Jeanny, and J.H. Dannenberg p107 is a suppressor of retinoblastoma development in pRb-deficient mice Genes Dev 12 11 1998 1599 1609
64. R. Bremner, D.C. Du, M.J. Connolly-Wilson, P. Bridge, K.F. Ahmad, and H. Mostachfi Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma Am J Hum Genet 61 3 1997 556 570
65. B.L. Gallie, G. Budning, G. DeBoer, J.J. Thiessen, G. Koren, and Z. Verjee Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy Arch Ophthalmol 114 11 1996 1321 1328
66. A.L. Murphree, J.G. Villablanca, W.F. Deegan 3rd, J.K. Sato, M. Malogolowkin, and A. Fisher Chemotherapy plus local treatment in the management of intraocular retinoblastoma Arch Ophthalmol 114 11 1996 1348 1356
67. B. Kremens, R. Wieland, H. Reinhard, D. Neubert, J.D. Beck, and T. Klingebiel High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma Bone Marrow Transplant 31 12 2003 281 284
68. R.M. Conway, T.M. Aaberg, and J.M. O'Brien Retinoblastoma M.E. Hartnett Pediatric retinal diseases: medical and surgical approaches 2004 Lippincott Williams & Wilkins Baltimore [Chapter 14]
69. H.S. Chan, P.S. Thorner, G. Haddad, and B.L. Gallie Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression Ophthalmology 98 9 1991 1425 1431
70. H. Calvert, I. Judson, and W.J. van der Vijgh Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity Cancer Surv 17 1993 189 217
71. J.W. Harbour, T.G. Murray, D. Hamasaki, N. Cicciarelli, E. Hernandez, and B. Smith Local carboplatin therapy in transgenic murine retinoblastoma Invest Ophthalmol Vis Sci 37 9 1996 1892 1898
72. B.H. Hayden, T.G. Murray, I.U. Scott, N. Cicciarelli, E. Hernandez, and W. Feuer Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule Arch Ophthalmol 118 11 2000 1549 1554
73. D.H. Abramson, C.M. Frank, and I.J. Dunkel A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma Ophthalmology 106 10 1999 1947 1950
74. A. Mulvihill, A. Budning, V. Jay, C. Vandenhoven, E. Heon, and B.L. Gallie Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma Arch Ophthalmol 121 8 2003 1120 1124
75. M.P. Nahum, M. Gdal-On, A. Kuten, G. Herzl, Y. Horovitz, and M. Weyl Ben Arush Long-term follow-up of children with retinoblastoma Pediatr Hematol Oncol 18 3 2001 173 179
76. F.L. Wong, J.D. Boice Jr, D.H. Abramson, R.E. Tarone, R.A. Kleinerman, and M. Stovall Cancer incidence after retinoblastoma: radiation dose and sarcoma risk JAMA 278 15 1997 1262 1267
77. B.C. Hayden, T.G. Murray, N. Cicciarelli, I.U. Scott, A. Alexandridou, and E. Hernandez Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma Arch Ophthalmol 120 3 2002 353 359
78. L. Sobrin, B.C. Hayden, T.G. Murray, N. Cicciarelli, I.U. Scott, and E. Hernandez External beam radiation "salvage" therapy in transgenic murine retinoblastoma Arch Ophthalmol 122 2 2004 251 257
79. T.G. Murray, J.M. O'Brien, R.A. Steeves, B.J. Smith, D.M. Albert, and N. Cicciarelli Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma Arch Ophthalmol 114 11 1996 1376 1381
80. T.G. Murray, D.B. Roth, J.M. O'Brien, W. Feuer, N. Cicciarelli, and A.M. Markoe Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma Arch Ophthalmol 114 11 1996 1385 1389
81. T.G. Murray, N. Cicciarelli, J.M. O'Brien, E. Hernandez, R.L. Mueller, and B.J. Smith Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma Arch Ophthalmol 115 10 1997 1286 1290
82. D.G. Dawson, J. Gleiser, M.L. Zimbric, S.R. Darjatmoko, M.J. Lindstrom, and S.A. Strugnell Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice Ophthalmology 110 4 2003 835 839
83. S.J. Sabet, S.R. Darjatmoko, M.J. Lindstrom, and D.M. Albert Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors Arch Ophthalmol 117 3 1999 365 370
84. C.L. Wilkerson, S.R. Darjatmoko, M.J. Lindstrom, and D.M. Albert Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice Clin Cancer Res 4 9 1998 2253 2256
85. S.M. Cohen, A.M. Saulenas, C.R. Sullivan, and D.M. Albert Further studies of the effect of vitamin D on retinoblastoma: inhibition with 1,25-dihydroxycholecalciferol Arch Ophthalmol 106 4 1988 541 543
86. D.M. Albert, D. Tapper, N.L. Robinson, and R. Felman Retinoblastoma and angiogenesis activity Retina 4 3 1984 189 194
87. D. Tapper, R. Langer, A.R. Bellows, and J. Folkman Angiogenesis capacity as a diagnostic marker for human eye tumors Surgery 86 1 1979 36 40
88. D.S. Walton, and W.M. Grant Retinoblastoma and iris neovascularization Am J Ophthalmol 65 4 1968 598 599
89. A.A. el-Zayat, D. Degen, S. Drabek, G.M. Clark, G.R. Pettit, and D.D. Von Hoff In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub) Anticancer Drugs 4 1 1993 19 25
90. D.J. Chaplin, G.R. Pettit, and S.A. Hill Anti-vascular approaches to solid tumor therapy: evaluation of combretastatin A4 phosphate Anticancer Res 19 1A 1999 189 195
91. G.G. Dark, S.A. Hill, V.E. Prise, G.M. Tozer, G.R. Pettit, and D.J. Chaplin Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature Cancer Res 57 10 1997 1829 1834
92. K. Grosios, P.M. Loadman, D.J. Swaine, G.R. Pettit, and M.C. Bibby Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma Anticancer Res 20 1A 2000 229 233
93. C. Malcontenti-Wilson, V. Muralidharan, S. Skinner, C. Christophi, D. Sherris, and P.E. O'Brien Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model Clin Cancer Res 7 4 2001 1052 1060
94. A.S. Boehle, B. Sipos, U. Kliche, H. Kalthoff, and P. Dohrmann Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model Ann Thorac Surg 71 5 2001 1657 1665
95. W. Landuyt, O. Verdoes, D.O. Darius, M. Drijkoningen, S. Nuyts, and J. Theys Vascular targeting of solid tumors: a major "inverse" volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas Eur J Cancer 36 14 2000 1833 1843
96. J. Griggs, J.C. Metcalfe, and R. Hesketh Targeting tumour vasculature: the development of combretastatin A4 Lancet Oncol 2 2 2001 82 87
97. A. Dowlati, K. Robertson, M. Cooney, W.P. Petros, M. Stratford, and J. Jesberger A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer Cancer Res 62 12 2002 3408 3416
98. J.P. Stevenson, M. Rosen, W. Sun, M. Gallagher, D.G. Haller, and D. Vaughn Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow J Clin Oncol 21 23 2003 4428 4438
99. A.F. Clark AL-3789: a novel ophthalmic angiostatic steroid Exp Opin Invest Drugs 6 1997 1867 1877
100. D. Ben Ezra, B.W. Griffin, G. Maftzir, N.A. Sharif, and A.F. Clark Topical formulations of novel angiostatic steroids inhibit corneal neovascularization Invest Ophthalmol Vis Sci 38 10 1997 1954 1962
101. B.L. Tolman, R.J. Collier, A.F. Clark, and J.S. Penn Effects of an angiostatic steroid on neovascularization in the rat model of ROP [abstract] Invest Ophthalmol Vis Sci 36 4 1995 S93
102. A.F. Clark, J. Mellon, X.Y. Li, D. Ma, H. Leher, and R. Apte Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate Invest Ophthalmol Vis Sci 40 9 1999 2158 2162
103. J.S. Penn, V.S. Rajaratnam, R.P. Collier, and A.F. Clark The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity Invest Ophthalmol Vis Sci 42 1 2001 283 290
104. D.J. D'Amico, M.F. Goldberg, H. Hudson, J.A. Jerdan, S. Krueger, and S. Luna Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy Retina 23 1 2003 14 23
105. K.L. Ferguson, J.L. Vanderluit, J.M. Hebert, W.C. McIntosh, E. Tibbo, and J.G. MacLaurin Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development EMBO J 21 13 2002 3337 3346
106. H. Xia, Q. Mao, H.L. Paulson, and B.L. Davidson siRNA-mediated gene silencing in vitro and in vivo Nat Biotechnol 20 10 2002 1006 1010